Associated Papers
Mutated DNMT3A creates a public HLADQ- binding neoantigen on acute myeloid leukemia.
van der Lee DI et al.
Frontiers in Immunology, 2025
40151616 (PubMed )
Supplement: DataSheet1.docx
Application of an NGS-based 28-gene panel in myeloproliferative neoplasms reveals distinct mutation patterns in essential thrombocythaemia, primary myelofibrosis and polycythaemia vera.
Delic S et al.
British Journal of Haematology, 2016
27447873 (PubMed )
Supplement: supplement_1.doc
ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.
Damaj G et al.
Plos One, 2014
24465546 (PubMed )
Supplement: pone.0085362.s001.pdf
Acquired mutations in ASXL1 in acute myeloid leukemia: prevalence and prognostic value.
Pratcorona M et al.
Haematologica, 2012
Select a paper to view details